SYRA Syra Health Corp: Rasio Total Utang marang Ekuitas

Syra Health Corp. (SYRA) generates revenue through engagements with pharmaceutical companies, government agencies, and schools by providing IT services, recruitment, and clinical trial support. Management possesses local expertise, although internal control systems require refinement. The daily price action, where the total debt-to-equity ratio stands at 0.00, highlights the potential for scaling government contracts and the implementation of cloud-based mental health analysis systems.

SYRA - Rasio Kabeh Utang marang Dana Pribadi Syra Health ing rentang 21.02.2024 - 31.05.2025

Rincian metrik lan analitis perusahaan Syra Health, Corp. (SYRA)

- rega saham lan konsensus proyeksi valuasi:
Rega saham Syra Health|SYRA - Target median analis
- data kapitalisasi saham perusahaan:
Biji pasar Syra Health|SYRA - Total Nilai Bisnis
- informasi kapitalisasi buku:
Nilai Akuntansi saben Saham Syra Health|SYRA - Nilai Akuntansi Perusahaan|Rasio Nilai Pasar marang Nilai Buku syrahealth.com|SYRA - Gunggung Aset Perusahaan
- indikator beban utang lan likuiditas:
Total Utang marang Modal Syra Health Corp.|SYRA - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Syra Health Corp.|SYRA - Utang agregat perusahaan|Rasio utang marang kapitalisasi buku Syra Health|SYRA - Gunggunge utang jangka dawa|Kewajiban jangka cendhak perusahaan Syra Health|Likuiditas cepet syrahealth.com
Analisis umum perusahaan:SYRA, Syra Health

Investors are verifying the issuer's financial stability by analyzing the debt-to-equity ratio to assess the risks of excessive leverage. By examining the debt-to-equity chart, one can determine how effectively Syra Health Corp. (SYRA) finances the hiring of a flexible staff of specialized medical and IT professionals using its own resources rather than external liabilities.

Analisis pesaing

VEEV (Veeva) - Total Utang marang Modal|Doximity Inc (DOCS) - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas HQY (HealthEquity Corp)|Utang Agregat marang Modal WAY|CorVel Corporation - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi PRVA|HURN - Utang marang Ekuitas|Certara Inc (CERT) - Rasio Total Utang marang Ekuitas|OMCL: Total Utang marang Modal|Utang marang Modal GoodRx Gold (GDRX)|SDGR (Schrodinger, Inc.) - Total Utang marang Modal|Rasio Utang marang Ekuitas PHR (phreesia.com)|Utang marang Ekuitas Omada Health (OMDA)|Koefisien Total Utang marang Modal Evolent Health Inc|HealthStream Corp - Rasio Total Utang marang Ekuitas|Definitive Corp (DH) - Utang marang Modal|CCSI - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi AGL (agilonhealth.com)|ABSI: Total Utang marang Modal|So-Young International Inc (SY) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas NRC|SPOK: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal OPRX|TBRG (trubridge.com) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal SLP (Simulations Plus)|Sophia Genetics (SOPH) - Utang marang Modal|Health Catalyst, Inc - Total Utang marang Modal|CCLD - Total Utang marang Modal|Research Solutions (RSSS) - Utang marang Ekuitas|DLHC (DLH Holdings) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas ONMD|SCNX (Scienture Holdings) - Utang Agregat marang Modal|Total Utang marang Modal HCTI|ISPC (ispecimen.com) - Rasio Kabeh Utang marang Dana Pribadi|Bullfrog AI - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi WORX|MSP Recovery - Total Utang marang Modal|iCoreConnect Inc. (ICCT) - Rasio Total Utang marang Ekuitas|TRxADE (MEDS) - Utang marang Ekuitas|Utang marang Modal Orgenesis Corporation (ORGS)|Utang marang Ekuitas R1 RCM, Inc.|SHCR: Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Streamline Health (STRM)|AMEH: Utang Agregat marang Ekuitas|Model N Corp - Rasio Total Utang marang Ekuitas|Koefisien Total Utang marang Modal NextGen Healthcare Corp (NXGN)